Exchange Traded Concepts »

Innate Pharma shares owned by Exchange Traded Concepts

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Exchange Traded Concepts from 13F filings

Historical chart of Exchange Traded Concepts investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Exchange Traded Concepts

Quarter filed Position value Share count Share price at filing
2024-03-31 $326k 113k 2.88
2023-12-31 $131k 47k 2.80
2023-09-30 $89k 35k 2.53
2023-06-30 $133k 42k 3.14

More positions owned by Exchange Traded Concepts

Spdr Ser Tr Nuveen Bloomberg (HYMB)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds Real Estate Etf (VNQ)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Meta Platforms Cl A (META)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Qualcomm (QCOM)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Technology (XLK)
Williams Companies (WMB)

View all positions for Exchange Traded Concepts

Top funds holding Innate Pharma

Exchange Traded Concepts
Millennium Management
Barclays
Rhumbline Advisers
Steward Partners Investment Advisory
UBS Group

View all funds holding Innate Pharma